U.S. flag

An official website of the United States government

NM_032638.5(GATA2):c.423C>A (p.Tyr141Ter) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 6, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001542181.1

Allele description [Variation Report for NM_032638.5(GATA2):c.423C>A (p.Tyr141Ter)]

NM_032638.5(GATA2):c.423C>A (p.Tyr141Ter)

Gene:
GATA2:GATA binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q21.3
Genomic location:
Preferred name:
NM_032638.5(GATA2):c.423C>A (p.Tyr141Ter)
HGVS:
  • NC_000003.12:g.128486175G>T
  • NG_029334.1:g.12013C>A
  • NM_001145661.2:c.423C>A
  • NM_001145662.1:c.423C>A
  • NM_032638.5:c.423C>AMANE SELECT
  • NP_001139133.1:p.Tyr141Ter
  • NP_001139134.1:p.Tyr141Ter
  • NP_116027.2:p.Tyr141Ter
  • LRG_295:g.12013C>A
  • NC_000003.11:g.128205018G>T
Protein change:
Y141*
Links:
dbSNP: rs781744898
NCBI 1000 Genomes Browser:
rs781744898
Molecular consequence:
  • NM_001145661.2:c.423C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001145662.1:c.423C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_032638.5:c.423C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Deafness-lymphedema-leukemia syndrome
Synonyms:
Lymphedema, primary, with myelodysplasia; Emberger syndrome
Identifiers:
MONDO: MONDO:0013540; MedGen: C3279664; Orphanet: 3226; OMIM: 614038
Name:
GATA2 deficiency with susceptibility to MDS/AML
Identifiers:
MONDO: MONDO:0042982; MedGen: CN300066

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001760849Molecular Pathology Research Laboratory, SA Pathology
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 6, 2021)
germlinecuration

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes22not providednot providednot providedcuration

Citations

PubMed

Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients.

Donadieu J, Lamant M, Fieschi C, de Fontbrune FS, Caye A, Ouachee M, Beaupain B, Bustamante J, Poirel HA, Isidor B, Van Den Neste E, Neel A, Nimubona S, Toutain F, Barlogis V, Schleinitz N, Leblanc T, Rohrlich P, Suarez F, Ranta D, Chahla WA, Bruno B, et al.

Haematologica. 2018 Aug;103(8):1278-1287. doi: 10.3324/haematol.2017.181909. Epub 2018 May 3.

PubMed [citation]
PMID:
29724903
PMCID:
PMC6068047

A landscape of germ line mutations in a cohort of inherited bone marrow failure patients.

Bluteau O, Sebert M, Leblanc T, Peffault de Latour R, Quentin S, Lainey E, Hernandez L, Dalle JH, Sicre de Fontbrune F, Lengline E, Itzykson R, Clappier E, Boissel N, Vasquez N, Da Costa M, Masliah-Planchon J, Cuccuini W, Raimbault A, De Jaegere L, Adès L, Fenaux P, Maury S, et al.

Blood. 2018 Feb 15;131(7):717-732. doi: 10.1182/blood-2017-09-806489. Epub 2017 Nov 16.

PubMed [citation]
PMID:
29146883
See all PubMed Citations (3)

Details of each submission

From Molecular Pathology Research Laboratory, SA Pathology, SCV001760849.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedcuration PubMed (3)

Description

PVS1, PS4_Moderate, PM2

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not provided2not provided

Last Updated: Dec 24, 2023